UBE2C and prostate adenocarcinoma: Also, upregulated UBE2C expression was significantly correlated with poor prognosis and disease free survival (DFS) of patients with ACC, KIRC, KIRP, LGG, LIHC, MESO, PAAD, Prostate adenocarcinoma (PRAD), THCA, Uterine corpus endometrial carcinoma (UCEC), and UVM (Figure 3B).